Eigen Therapeutics

No two cancers are the same. Let's treat it that way.

Redwood City, United States · Founded 2021 · $7.0M raised

Employees
1–10
Founded
2021
Business Model
B2B
Total Funding
$7.0M
Last Round
$7.0M SeedDec 2022
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Eigen Therapeutics is a biotechnology company developing co-therapies that improve the efficacy of targeted cancer treatments by modulating tumor cell-surface targets. Its AI-driven discovery platform combines high-throughput biology, laboratory robotics, and machine learning to identify combination therapies for cancers with heterogeneous target expression. The approach expands patient eligibility for existing targeted therapies while reducing side effects.

Summary

Eigen Therapeutics is a Biotech company based in Redwood City, United States, founded in 2021. It has raised $7.0M in total across 1 round, most recently a $7.0M Seed round in Dec 2022. Investors include First Round Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedDec 2022
$7.0M

Investors

Similar Companies

OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Eigen Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/eigen-therapeutics"><img src="https://indexed.vc/api/badge/company/eigen-therapeutics" alt="Eigen Therapeutics on Indexed.vc" width="260" height="76" /></a>